Avestria Ventures

Investor type

PE / VC

Founded

2018

AUM

$200 M

Location

San Francisco, California, United States

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Series B

Region of investment

North America

ESG Focus

Impact investor Women
Investor profile last updated: 21 August, 2026

Profile

Avestria Ventures is a venture capital firm based in the San Francisco Bay Area, specializing in women's health and female-led life science ventures. Founded by Harvard Business School classmates, the firm boasts a diverse team including partners like Linda Greub, CFA, and Tracy Dooley, MD. Its mission is to invest in overlooked and undervalued markets, focusing specifically on women’s healthcare and female founders in the life sciences, aiming to address the disparity in venture capital funding for these sectors.

Avestria Ventures targets early-stage businesses that utilize technology or data to improve healthcare quality and access while reducing costs. Their primary focus includes conditions affecting women exclusively or disproportionately. The firm supports companies that are evidence-based, capable of inducing clinical or behavioral change, and have scalable commercialization plans. While specific fund details vary, Avestria Ventures prioritizes strategic investments in healthcare that can leverage existing infrastructure and healthcare policies.

Notable portfolio companies include Axena Health, Clarified Precision Medicine, ENB Therapeutics, and Elucent Medical. Avestria Ventures is committed to empowering female founders and enhancing the landscape of women’s healthcare through strategic investments.

Industry

Healthcare Services Biotechnology AI MedTech Life Sciences HealthTech Digital Medical Devices

Avestria Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Avestria Ventures Fund I
Venture Capital (VC)
Biotechnology
Digital
Healthcare Services
Medical Devices
HealthTech
Seed
Series A
North America
$5-10 m
$50 M
July 2019
Avestria Ventures Fund II
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Seed
Series A
North America
$5-10 m
$100 M
June 2022
Women's Health and Female-Led Life Science Fund
Biotechnology
AI
MedTech
Life Sciences
HealthTech
Seed
Series A
Series B
North America
$1-5 m
September 2026

Contacts

Name
Title
Email
avatar
Linda Greub Managing Partner
Managing Partner
l•••@•••
avatar
Margot Shapiro Managing Partner
Managing Partner
m•••@•••
Upgrade to see contacts
avatar
it4FGgRkWyvhxoH7 it4FGgRkWyvhxoH7
it4FGgRkWyvhxoH7
avatar
it4FGgRkWyvhxoH7 it4FGgRkWyvhxoH7
it4FGgRkWyvhxoH7
avatar
it4FGgRkWyvhxoH7 it4FGgRkWyvhxoH7
it4FGgRkWyvhxoH7
Investment-team contacts for Avestria Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Avestria Ventures

Avestria Ventures is a venture capital and private equity firm. It backs companies at Series A, Seed and Series B, writing tickets of $1-5 m.
Avestria Ventures is located in San Francisco, California, United States.
Avestria Ventures was founded in 2018.
Avestria Ventures invests in companies and startups in Healthcare Services, Biotechnology, AI, MedTech, Life Sciences, HealthTech, Digital, Medical Devices.
Avestria Ventures invests in companies and startups in North America.
Avestria Ventures invests in companies and startups at Series A, Seed, Series B.
Avestria Ventures usually invests $1-5 m on average.
Avestria Ventures has around $200m assets under management.
Avestria Ventures last fund was created/launched in 2022-06-16
Avestria Ventures invests and supports Women startups and founders.
Yes, Avestria Ventures is impact investor.
Avestria Ventures can be reached through its website avestria.vc, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Avestria Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Avestria Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.